Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera
The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed obesity-drug developer.
Source link 
The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed obesity-drug developer.
Source link